Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Autoimmune Disorders

Free Subscription 06.07.2026 1 Ann Neurol 13 BMC Neurol 2 Brain 2 Intern Med 1 J Autoimmun 1 J Clin Endocrinol Metab 5 J Neurol 4 J Rheumatol 9 Mult Scler 2 N Engl J Med 1 Neurol Clin Pract 1 Neurology 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. WU T, Jiang Y, Lin J, Zhang J, et al
   AQP4 and MOG Characterize the Autoantibody Landscape of Checkpoint Blockade-Induced Optic Neuritis.
   Ann Neurol. 2026 Jul 3. doi: 10.1002/ana.78297.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. WANG Y, Cui L, Zhang N
   Case report: anti-NMDAR encephalitis with cerebellar ataxia as the initial manifestation.
   BMC Neurol. 2026;26:330.
   PubMed         Abstract available
   
   
3. WAN F, Wu X, Tan Y, Guo Y, et al
   Unexpected pregnancy in a patient with AQP4-IgG + NMOSD after treatment with inebilizumab: a case report.
   BMC Neurol. 2026;26:125.
   PubMed         Abstract available
   
   
4. ZHAO S, Wang Y, Li Z, Weng Q, et al
   Infection as a potential trigger in glial fibrillary acidic protein astrocytopathy: a case report and review of immunotherapeutic strategies.
   BMC Neurol. 2026;26:109.
   PubMed         Abstract available
   
   
5. HU S, Wang X, Wu H, Hong R, et al
   Biomarkers for satralizumab treatment in neuromyelitis optica spectrum disorders: a prospective case series.
   BMC Neurol. 2026;26:156.
   PubMed         Abstract available
   
   
6. WANG Y, Zhao Y, Lu C, Wang L, et al
   Recurrent cerebral venous thrombosis associated with IgG4-related hypertrophic pachymeningitis: Case report and literature review.
   BMC Neurol. 2026;26:279.
   PubMed         Abstract available
   
   
7. LIU Y, Wu C, Chen H, Hong D, et al
   Anti-mGluR encephalitis: case series and literature review.
   BMC Neurol. 2026;26:150.
   PubMed         Abstract available
   
   
8. DE MELO PS, de Oliveira Costa E, Ribeiro CMB, de Jesus PAP, et al
   Monoclonal antibodies in neuromyelitis optica spectrum disorder: a systematic review and meta-analysis.
   BMC Neurol. 2026;26:185.
   PubMed         Abstract available
   
   
9. ZHANG M, Liu X, Cheng S, Ruan Y, et al
   A case report: primary central nervous system lymphoma misdiagnosed as neuromyelitis optica.
   BMC Neurol. 2026 Feb 16. doi: 10.1186/s12883-026-04711.
   PubMed        
   
   
10. SARAYA AW, Tunvirachaisakul C, Worachotsueptrakun K, Katasrila P, et al
    Screening for neuronal antibodies in cognitive impairment and dementia clinics: a prospective multicenter study.
    BMC Neurol. 2026;26:96.
    PubMed         Abstract available
    
    
11. GNANAPAVAN S, Arun T, Gallagher P, Rushworth M, et al
    Evaluating the potential of sNfL as a biomarker in MS management in the UK: insights from SUNLIT survey.
    BMC Neurol. 2025;26:50.
    PubMed         Abstract available
    
    
12. FROIDEVAUX C, Provost C, Mele N
    A case of isolated brainstem bright spotty lesion in a patient with AQP4-positive NMOSD.
    BMC Neurol. 2026;26:284.
    PubMed         Abstract available
    
    
13. ZHANG J, Ling L, Xiang L, Li W, et al
    Role of serum complement C3 in blood-brain barrier injury and prognosis of anti-NMDAR encephalitis.
    BMC Neurol. 2026;26:187.
    PubMed         Abstract available
    
    
14. WANG A, Li H, Li D, Wang K, et al
    Lambert-Eaton myasthenic syndrome presenting with occult mediastinal small cell carcinoma and positivity for anti-CV2/CRMP5 and anti-SOX1 antibodies: a case report.
    BMC Neurol. 2025;26:3.
    PubMed         Abstract available
    
    

    
    Brain

15. HAY CM, Mahjoub A, Vidarsson L, Soltanieh S, et al
    Retinal hyper-reflective foci link retinal and cortical pathology in paediatric multiple sclerosis.
    Brain. 2026 Jul 1:awag235. doi: 10.1093.
    PubMed         Abstract available
    
    
16. DUGAST E, Shah S, Vogel I, Loret A, et al
    Blood cytotoxic natural killer-like CD8 + CD94+ T cells migrate to the brain and predict multiple sclerosis severity.
    Brain. 2026 Jun 30:awag227. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Intern Med

17. ICHIKAWA M, Suzuki N, Watanabe N, Iida T, et al
    A Rare Case of Amyloid Goiter Suspected to Be Malignant on Imaging Findings.
    Intern Med. 2026;65:1794-1798.
    PubMed         Abstract available
    
    
18. MATSUMOTO T, Suga H, Matoba T, Iri A, et al
    A Marked Improvement in Mild but Progressive Autoimmune Pulmonary Alveolar Proteinosis Treated with Inhaled Granulocyte-Macrophage Colony-Stimulating Factor Therapy: A Case Report.
    Intern Med. 2026 Jun 27. doi: 10.2169/internalmedicine.7389.
    PubMed         Abstract available
    
    

    
    J Autoimmun

19. OH TK, Song IA
    Neonatal total parenteral nutrition and the risk of childhood autoimmune diseases: A nationwide population-based study of 2.3 million children.
    J Autoimmun. 2026;162:103596.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

20. GATTA E, Delbarba A, Maltese V, Buoso C, et al
    The Extra X Chromosome and Autoimmune Susceptibility in Klinefelter Syndrome.
    J Clin Endocrinol Metab. 2026 Jul 4:dgag268. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Neurol

21. ARATAKE Y, Yoshinaga K, Ashida S, Fujii C, et al
    Beyond dissemination criteria: lesion-based longitudinal MRI of atypical demyelinating lesions at the boundary of multiple sclerosis.
    J Neurol. 2026;273:438.
    PubMed         Abstract available
    
    
22. BOVE R, Langdon D, Maciejowski M, Jasinska E, et al
    Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS study.
    J Neurol. 2026;273:434.
    PubMed         Abstract available
    
    
23. CALISTRI V, Pezzella FR, Prosperini L
    Triple-crush mechanism in multiple sclerosis-associated trigeminal neuralgia.
    J Neurol. 2026;273:431.
    PubMed        
    
    
24. HU Y, Wen M, Wen L, Cheng R, et al
    Comorbid autoimmune disease in stiff-person syndrome spectrum disorder: a systematic review and meta-analysis.
    J Neurol. 2026;273:442.
    PubMed         Abstract available
    
    
25. KOKS F, Reubens F, van der Zee H, Briede JJ, et al
    The dual role of mTOR in multiple sclerosis pathophysiology: a systematic review.
    J Neurol. 2026;273:441.
    PubMed         Abstract available
    
    

    
    J Rheumatol

26. MORAND EF, Jones SA
    PROducing More Evidence to Reduce Glucocorticoids in Systemic Lupus Erythematosus: Putting Patient-Reported Outcomes in the Picture.
    J Rheumatol. 2026 Jul 1:jrheum.2026-0502. doi: 10.3899/jrheum.2026-0502.
    PubMed        
    
    
27. DEL PAPA N, Greco R
    Predicting Relapse After Autologous Hematopoietic Cell Transplantation in Systemic Sclerosis: What Autoantibodies Can and Cannot Tell Us.
    J Rheumatol. 2026 Jul 1:jrheum.2026-0544. doi: 10.3899/jrheum.2026-0544.
    PubMed        
    
    
28. KOBRIN DM, Brown DG, Burbelo PD, Workman L, et al
    Examination of HLA-DRB1*15-linked Candidate Antigens in Still Disease With and Without Lung Disease and Drug-Associated Immune Reactions.
    J Rheumatol. 2026;53:816-822.
    PubMed         Abstract available
    
    
29. YILDIZ M, Konte EK, Aslan E, Akay N, et al
    Classification of Nonsystemic Juvenile Idiopathic Arthritis Using the Provisional Paediatric Rheumatology International Trials Organisation Criteria.
    J Rheumatol. 2026;53:800-807.
    PubMed         Abstract available
    
    

    
    Mult Scler

30. BRIGGS FB, Litwiler J, Montini F, Fereidan Esfahani M, et al
    Tobacco smoking disrupts bile acid and tryptophan metabolism in multiple sclerosis.
    Mult Scler. 2026 Jul 1:13524585261454207. doi: 10.1177/13524585261454207.
    PubMed         Abstract available
    
    
31. GUILFOYLE D, Ward K, Klistorner S, Lizak N, et al
    Impact of multiple sclerosis disease-modifying therapies on chronic lesion tissue expansion.
    Mult Scler. 2026 Jul 1:13524585261459228. doi: 10.1177/13524585261459228.
    PubMed         Abstract available
    
    
32. SUTHIPHOSUWAN S, Lim TR, Raufdeen F, Punpichet M, et al
    Missed radiologic disease activity by conventional side-by-side MRI comparison is associated with future disease activity in multiple sclerosis: Adopting semiautomated coregistration-fusion into clinical practice.
    Mult Scler. 2026 Jul 1:13524585261453816. doi: 10.1177/13524585261453816.
    PubMed         Abstract available
    
    
33. MACMILLAN EL, Russell-Schulz B, Alejo G, Harp C, et al
    Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2 years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab.
    Mult Scler. 2026 Jun 30:13524585261456964. doi: 10.1177/13524585261456964.
    PubMed         Abstract available
    
    
34. YOO PY, Zarandi A, Stephens S, To T, et al
    Racial identity, marginalization, and depression in pediatric-onset multiple sclerosis.
    Mult Scler. 2026 Jun 29:13524585261453239. doi: 10.1177/13524585261453239.
    PubMed         Abstract available
    
    
35. HEDSTROM AK, Stridh P, Hillert J, Olsson T, et al
    Interaction between smoking and HLA-A*02:01 in multiple sclerosis progression.
    Mult Scler. 2026 Jul 3:13524585261453243. doi: 10.1177/13524585261453243.
    PubMed         Abstract available
    
    
36. BERGMANN C, Jackson D, Nicholson R, Bleyer L, et al
    Invisible symptoms in multiple sclerosis and their impact on social role participation: A multidimensional analysis.
    Mult Scler. 2026 Jul 3:13524585261459835. doi: 10.1177/13524585261459835.
    PubMed         Abstract available
    
    
37. CHU NY, Roberts JI, Hunt DJ, Kuipers D, et al
    Comparative effectiveness of rituximab versus ocrelizumab in relapsing multiple sclerosis on clinical relapses and radiological outcomes in British Columbia, Canada.
    Mult Scler. 2026 Jul 3:13524585261453817. doi: 10.1177/13524585261453817.
    PubMed         Abstract available
    
    
38. MULLAN G, Ford HL, Blackall P, Bongol D, et al
    UK consensus on pregnancy in multiple sclerosis: An update to 'Association of British Neurologists' guidance.
    Mult Scler. 2026 Jul 3:13524585261454551. doi: 10.1177/13524585261454551.
    PubMed         Abstract available
    
    

    
    N Engl J Med

39. HAUSER SL
    Advances in Multiple Sclerosis.
    N Engl J Med. 2026;395:54-68.
    PubMed         Abstract available
    
    
40. TORKILDSEN O, Brustad HK, Hogestol EA, Alstadhaug KB, et al
    Rituximab versus Ocrelizumab in Newly Diagnosed Relapsing Multiple Sclerosis.
    N Engl J Med. 2026;395:44-53.
    PubMed         Abstract available
    
    

    
    Neurol Clin Pract

41. SOLOMON AJ, Zakaria M, Saylor DR, Viswanathan S, et al
    Global Access to Diagnostic Paraclinical Testing Incorporated in the 2024 Revised McDonald Criteria: Disparities and Opportunity.
    Neurol Clin Pract. 2026;16:e200633.
    PubMed         Abstract available
    
    

    
    Neurology

42. ENGELS D, Schindler P, Havla J, Fischer K, et al
    Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.
    Neurology. 2026;107:e218199.
    PubMed         Abstract available
    
    

    
    Thyroid

43. CHUNG HW, Cho SG, Oh D, Kwon K, et al
    CT-Free Quantitative Thyroid SPECT Based on Artificial Intelligence: A Prospective Multicenter Noninferiority Clinical Trial.
    Thyroid. 2026 Apr 7:10507256261440401. doi: 10.1177/10507256261440401.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum